JenkinsSCHeatonRWFultonTJMoxhamJ. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest1987; 91: 804–7.
2.
MestitzHCoplandJMMcDonaldCF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest1989; 96: 1237–40.
3.
ShimCSWilliamsMH. Effect of bronchodilator therapy administered by canister versus jet nebulizer. J Allergy Clin Immunol1984; 73: 387–90.
4.
SalzmanGAPyszczynskiDR. A comparison of two delivery methods of aerosolized metaproterenol sulfate. J Asthma1986; 23: 297–301.
5.
SalzmanGASteeleMTPribbleJPElenbaasRMPyszczynskiDR. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction—comparison of two delivery methods. Chest1989; 95: 1017–20.
6.
BerryRBShintoRAWongFHDesparsJALightRW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest1989; 96: 1241–6.
7.
BerenbergMJBaigelmanW. Comparison of metered-dose inhaler attached to an aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients. J Asthma1985; 22: 87–92.
8.
SummerWElstonRTharpeLNelsonSHaponikEF. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med1989; 149: 618–23.
9.
GayPCPatelHGNelsonSBGillesBHubmayrRD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest1991; 99: 66–71.
10.
CravenDELichtenbergDAGoularteTAMakeBJMcCabeWR. Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med1984; 77: 834–8.
11.
NewmanSPPaviaDMorenFSheahanNFClarkeSW. Deposition of pressurised aerosols in the human respiratory tract. Thorax1981; 36: 52–5.
12.
NewmanSPMorenFPaviaDLittleFClarkeSW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis1981; 124: 317–20.
13.
DolovichMBRuffinRERobertsRNewhouseMT. Optimal delivery of aerosols from metered dose inhalers. Chest1981; 80 (6: suppl):911—5.
14.
SpiroSGSinghCATolfreeSEJPartridgeMRShortMD. Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis. Thorax1984; 39: 432–5.
15.
FullerHDDolovichMBPosmituckGPackWWNewhouseMT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis1990; 141: 440–4.
16.
FullerHDDolovichMBPosmituckGPackWWNewhouseM. Aerosol deposition to the lungs by MDI in ventilated patients: ET tubes vs tracheostomy (abstract). Chest1990; 98: 27S.
17.
CroganSJBishopMJ. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology1989; 70: 1008–10.
18.
DonnaEKimCSBoszormenyiGMarcialEGoldM. Delivery efficiency of 3 metered dose inhaler aerosols and 2 actuators via an endotracheal tube (abstract). Anesthesiology1988; 69: A838.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. revised. Washington: APA Press, 1987: 245–7.
27.
MurphyDLPatoMTPigottTA. Obsessive-compulsive disorder: Treatment with serotonin-selective uptake inhibitors, azapirones, and other agents. J Clin Psychopharmacol1990; 10 (suppl):91S–100S.
28.
TowbinKELeckmanJFCohenDJ. Drug treatment of obsessive-compulsive disorder: A review of findings in the light of diagnostic and metric limitations. Psychiatr Dev1987; 1: 25–50.
29.
KnobenJEAndersonPO, eds. Handbook of clinical drug data. 6th ed.Hamilton, IL: Drug Intelligence Publications, 1989: 588.
30.
PatoMTPigottTAHillJLGroverGNBernsteinSMurphyDL. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Am J Psychiatry1991; 148: 127–9.
31.
JenikeMABaerL. An open trial of buspirone in obsessive-compulsive disorder. Am J Psychiatry1988; 145: 1285–6.
32.
TanquaryJMasandP. Paradoxical reaction to buspirone augmentation of fluoxetine (letter). J Clin Psychopharmacol1990; 10: 377.
33.
PatoMTGluhoskiV. Serotonin and effect sizes of antiobsessive agents (letter). Am J Psychiatry1992; 149: 420–1.
34.
JenikeMAHymanSBaerLHollandAMinichielloWEButtolphL. A controlled trial of fluvoxamine in obsessive-compulsive disorder: Implications for a serotonergic therapy. Am J Psychiatry1990; 147: 1209–15.
35.
WattsVSNeillJR. Buspirone in obsessive-compulsive disorder (letter). Am J Psychiatry1988; 145: 1606.
36.
MarkovitzPJStagnoSJCalabreseJR. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry1990; 147: 798–800.
37.
JenikeMABaerLButtolphL. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. Clin Psychiatry1991; 52: 13–1.
38.
AlessiNBosT. Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder (letter). Am J Psychiatry1991; 148: 1605–6.
GadekJEHoseaSWGelfandJAFrankMM. Response of variant hereditary angioedema phenotypes to danazol therapy. J Clin Invest1979; 64: 280–6.
44.
FrankMMSergentJSKaneMAAllingDW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: A double-blind study. N Engl J Med1972; 286: 808–12.
45.
ShefferALAustenKFRosenFS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med1972; 287: 452–4.
46.
SpauldingWB. Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med1960; 53: 739–45.
47.
DavisPJDavisFBCharacheP. Long-term therapy of hereditary angioedema (HAE): Preventive management with fluoxymesterone and oxymetholone in severely affected males and females. Johns Hopkins Med J1974; 135: 391–8.
48.
GelfandJASherinsRJAllingDWFrankMM. Treatment of hereditary angioedema with danazol. N Engl J Med1976; 295: 1444–8.
49.
BlackmoreWP. Danazol in the treatment of hereditary angio-neurotic oedema. J Int Med Res1977; 5 (suppl 3):38—43.
50.
RothbachCGreenRLLevineMIFiremanP. Prophylaxis of attacks of hereditary angioedema. Am J Med1979; 66: 681–3.
51.
AgostoniAMarasiniBCicardiMMartignoniGC. Intermittent therapy with danazol in hereditary angioedema (letter). Lancet1978; 1: 453.
52.
ChngHHBoeyML. Hereditary angioedema: Diagnosis and management. Singapore Med J1990; 31: 177–9.
FabianiJEPaulinPSimkinGLeoniJPalombaraniSSquiqueraL. Hereditary angioedema: Therapeutic effect of danazol on C4 and C1 esterase inhibitors. Ann Allergy1990; 64: 388–92.
55.
HoseaSWSantaellaMLBrownEJBergerMKatushaKFrankMM. Long-term therapy of hereditary angioedema with danazol. Ann Intern Med1980; 93: 809–12.
56.
ZurloJJFrankMM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril1990; 54: 64–72.
57.
Physicians' desk reference. 46th ed.Montvale, NJ: Medical Economics Data, 1992: 2046–7.